SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    UK CBD brand continues expansion across US

    By
    Home / UK CBD brand continues expansion across US

    Chill Brands has confirmed a new sales distribution partner and an expansion of its US retail store programme.

    Consumer package goods company, Chill Brands, has received an initial purchase order totalling in excess of $20,000.

    The order has come from a large national distributor serving a number of popular tobacco and liquor store chains. Following the sale, Chill Brands’ existing range of CBD products will enter an additional 60 stores across the Western United States.

    Read more: Chill Brands enters agreement for US CBD distribution

    Chill Brands CEO, Callum Sommerton, commented: “We are thrilled to be continuing our store rollout and are excited to be activating 60 new stores. 

    “The Chill brand has enjoyed a warm reception from the new locations it has entered during the past few months, where our novel tobacco alternative products have attracted sustained attention from relevant consumers.

    “It is important to recognise that CBD is a unique product which is best suited to specialist outlets, as reflected by our updated rollout strategy. 

    “We continue to take steps to proliferate Chill CBD products throughout the US retail environment and look to growing our store footprint further.”

    The 60 new stores will now join 20 Colorado-based independent retail locations and 20 licensed dispensary outlets that commenced sales and pilot programmes of Chill Brands’ products during Autumn 2022.

    The company has stated that this latest retail sales developments build on its existing presence in 600 stores including Yesway/Allsup’s and branches of Smoker Friendly. Chill Brands’ recent activity represents a retail footprint expansion of more than 15%.

    Chill Brands will now continue working with its distribution partners to extend its sustainable and targeted rollout to retailers throughout the US.

    Stephanie Price

    Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine ‘Game Theory’ focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on “Medical Cannabis Explained”.